MwanzoVRTX34 • BVMF
add
Vertex Pharmaceuticals Inc BDR
Bei iliyotangulia
R$ 529.20
Bei za siku
R$ 529.20 - R$ 529.20
Bei za mwaka
R$ 501.84 - R$ 748.45
Thamani ya kampuni katika soko
101.15B USD
Wastani wa hisa zilizouzwa
elfu 1.11
Uwiano wa bei na mapato
-
Mgao wa faida
-
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.96B | 12.06% |
Matumizi ya uendeshaji wa biashara | 1.30B | 4.97% |
Mapato halisi | 1.03B | 128.74% |
Kiwango cha faida halisi | 34.84 | 125.65% |
Mapato kwa kila hisa | 4.52 | 135.23% |
EBITDA | 1.21B | 21.94% |
Asilimia ya kodi ya mapato | 19.49% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 6.38B | 10.13% |
Jumla ya mali | 24.04B | 19.39% |
Jumla ya dhima | 6.86B | 28.07% |
Jumla ya hisa | 17.18B | — |
hisa zilizosalia | 256.39M | — |
Uwiano wa bei na thamani | 7.90 | — |
Faida inayotokana na mali | 12.30% | — |
Faida inayotokana mtaji | 15.66% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.03B | 128.74% |
Pesa kutokana na shughuli | 1.07B | 128.59% |
Pesa kutokana na uwekezaji | -484.50M | -4.49% |
Pesa kutokana na ufadhili | -349.20M | 2.62% |
Mabadiliko halisi ya pesa taslimu | 296.60M | 106.48% |
Mtiririko huru wa pesa | 910.06M | 44.49% |
Kuhusu
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1989
Makao Makuu
Tovuti
Wafanyakazi
6,100
